Study guide

8.3 Pharmacist Immunization Administration Authority

Oklahoma MPJE Pharmacy Jurisprudence Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Introduction & Exam Overview

1.1 Oklahoma MPJE Format, Blueprint & Passing Standards 1.2 Navigating Oklahoma & Federal Pharmacy Law Hierarchy

2 Chapter 2: State Board Governance & Administrative Framework

2.1 Oklahoma State Board of Pharmacy Structure & Powers 2.2 Disciplinary Procedures, Sanctions & Hearings 2.3 Impaired Pharmacist Recovery Program & Duty to Report

3 Chapter 3: Pharmacist Licensure & Continuing Education

3.1 Pharmacist Licensure Qualifications & Examination Rules 3.2 Reciprocity & Foreign Pharmacy Graduates 3.3 Annual License Renewal & Continuing Education Mandates 3.4 Inactive Status, Late Renewal & License Reinstatement

4 Chapter 4: Pharmacy Interns, Preceptors & Supportive Personnel

4.1 Pharmacy Intern Qualifications & Preceptor Standards 4.2 Experiential Intern Hours, Credit & Board Reporting 4.3 Pharmacy Technician Permitting & Training Requirements 4.4 Pharmacist-to-Technician Ratios & Scope of Supportive Duties

5 Chapter 5: Prescription Validity & Prescriber Authority

5.1 Legal Requirements of a Valid Prescription 5.2 Prescriptive Authority & Scopes of Practice in Oklahoma 5.3 The Pharmacist's Corresponding Responsibility & Red Flags 5.4 Out-of-State, Military & Foreign Prescriptions

6 Chapter 6: Electronic Prescribing & Controlled Substance Schedules

6.1 Oklahoma Electronic Prescribing Mandate (EPCS) 6.2 Federal & Oklahoma Controlled Dangerous Substance Schedules 6.3 Scheduled Listed Chemical Products (SLCP) & Pseudoephedrine Sales 6.4 Schedule V Non-Prescription (Exempt) Controlled Substances

7 Chapter 7: Controlled Substance Dispensing & Opioid Limits

7.1 Schedule II Prescribing & Dispensing Regulations 7.2 Emergency Schedule II Oral Authorizations 7.3 Partial Filling of Schedule II Prescriptions (CARA & Title 63) 7.4 Oklahoma Opioid Prescribing Limits for Acute Pain

8 Chapter 8: Patient Counseling, Safety & Clinical Pharmacy Services

8.1 Patient Counseling Mandates & OBRA '90 8.2 Prospective Drug Utilization Review (DUR) Requirements 8.3 Pharmacist Immunization Administration Authority 8.4 Naloxone Standing Orders, Overdose Prevention & Clinical Protocols 8.5 Patient Confidentiality, HIPAA Privacy & Health-Record Protection

9 Chapter 9: Dispensing Standards, Generic Substitution & Labeling

9.1 Oklahoma Generic Drug Substitution Laws (Orange Book) 9.2 Biosimilar & Interchangeable Biological Products (Purple Book) 9.3 Prescription Refill Limits & Emergency Maintenance Fills 9.4 Prescription Labeling, Poison Prevention Packaging (PPPA) & USP Standards 9.5 Expired, Adulterated, Misbranded & Recalled Drug Products 9.6 Nonprescription Drug Labeling, Packaging & Repackaging 9.7 Returning & Reusing Drugs: Return-to-Stock, Donation & Disposal

10 Chapter 10: Prescription Transfers, Delivery & Monitoring Systems

10.1 Prescription Transfer Rules (Controlled vs. Non-Controlled) 10.2 Oklahoma Prescription Monitoring Program (OK PMP / PMP AWARxE) 10.3 Central Fill, Mail-Order & Prescription Delivery Regulations 10.4 Automated Dispensing Systems (ADS) & Remote Pharmacy Services

11 Chapter 11: Pharmacy Permits, Facilities & Operational Standards

11.1 Oklahoma Pharmacy Licenses & Permits 11.2 Pharmacist-in-Charge (PIC) Governance & Requirements 11.3 Physical Plant, Security & Sanitation Standards 11.4 Pharmacy Permanent Closing & Change of Ownership

12 Chapter 12: Controlled Substance Management, Ordering & Security

12.1 Pharmacy DEA & OBNDD Registration Requirements 12.2 Controlled Substance Ordering (DEA Form 222 & CSOS) 12.3 Controlled Substance Physical Inventory Requirements 12.4 Theft, Significant Loss & CDS Destruction (DEA Form 106 & Form 41)

13 Chapter 13: Compounding Standards & Institutional Practice

13.1 Non-Sterile (USP <795>) & Sterile (USP <797>) Compounding 13.2 Hazardous Drug Handling (USP <800>) 13.3 Hospital & Institutional Pharmacy Operations (Hospital Pharmacies & Drug Rooms) 13.4 Nuclear, Charitable & Specialty Pharmacy Standards

8.3 Pharmacist Immunization Administration Authority

Key Takeaways Explain This Topic AI

Under 59 O.S. § 353.30(C), a pharmacist who has completed Board-approved training may administer FDA-approved or FDA-authorized immunizations WITHOUT a patient-specific prescription, standing order, or similar arrangement, and may administer therapeutic injections on a prescriber's order.

Oklahoma's statute and Board rules set NO minimum patient age for pharmacist-administered immunizations; any age floor a candidate has memorized (12, 14, 18) is not an Oklahoma rule.

A pharmacist must obtain an immunization permit from the Board ($25 fee) and display it in the pharmacy, and must maintain competency through current CPR certification plus 1 hour of immunization-related ACPE-accredited or Board-approved CE annually (OAC 535:10-11-3, 535:10-11-4).

An Oklahoma-licensed intern who completes an approved immunization training program while working under a pharmacist preceptor who holds immunization registration is exempt from separate immunization registration (OAC 535:10-11-4(d)).

Last updated: August 2026

8.3 Pharmacist Immunization Administration Authority

Core Legal Standard: Title 59 O.S. § 353.30(C) grants Oklahoma pharmacists unusually broad, independent immunization authority. A pharmacist who has completed the requisite Board-approved training "may administer therapeutic injections on orders from a licensed prescriber, and may administer immunizations that have been approved or authorized by the Food and Drug Administration without a patient-specific prescription, standing order or similar arrangement ." Two consequences follow that candidates routinely get wrong: (1) no physician protocol or standing order is needed for immunizations — only for therapeutic injections; and (2) the statute and OAC 535:10-11 set no minimum patient age . If an option offers you an Oklahoma age floor of 12, 14, or 18 for vaccines, it is a distractor.

1. Statutory Authority & Governance

The expansion of clinical pharmacy practice in Oklahoma explicitly recognizes pharmacists as frontline public health immunizers. The legal framework is governed by:

Oklahoma Pharmacy Act: Title 59 O.S. § 353.30 (Administration of immunizations and vaccines).

Board of Pharmacy Regulations: OAC 535:10-11 (Immunizations by Pharmacists and Interns).

Independent authority for immunizations: No standing order, protocol, or patient-specific prescription is required for an FDA-approved or FDA-authorized immunization (59 O.S. § 353.30(C)).

Prescriber order required for therapeutic injections: The same subsection draws the line clearly — therapeutic injections (as distinct from immunizations) may be administered only "on orders from a licensed prescriber."

Rulemaking posture: The Board develops the training and administration rules in consultation with the State Board of Medical Licensure and Supervision and the State Board of Osteopathic Examiners (59 O.S. § 353.30(A)–(B)). +------------------------------------------------------------------------------------------------+

  • | OKLAHOMA PHARMACIST IMMUNIZATION RULES |
  • +------------------------------------+-----------------------------------------------------------+
  • | Governing Authority: | Title 59 O.S. § 353.30 & OAC 535:10-11 |
  • | Immunizations: | NO patient-specific Rx, standing order, or protocol |
  • | | required (59 O.S. 353.30(C)) |
  • | Therapeutic Injections: | Require an order from a licensed prescriber |
  • | Minimum Patient Age: | NONE set by Oklahoma statute or Board rule |
  • | Board Credential: | Immunization PERMIT required before administering; $25 |
  • | | fee; must be displayed in the pharmacy (535:10-11-4) |
  • | Mandatory Training: | Approved ACPE immunization training course (535:10-11-3) |
  • | Life Support Credential: | Current CPR certification (535:10-11-3(c)) |
  • | Annual CE: | 1 hour immunization-related ACPE or Board-approved CE |
  • | State Registry Reporting: | Mandatory reporting to OSIIS |
  • | Adverse Event Reporting: | Mandatory reporting to VAERS |
  • | Emergency Preparedness: | Immediate access to IM Epinephrine & Diphenhydramine |
  • | Record Retention: | Minimum TWO (2) YEARS |
  • +------------------------------------+-----------------------------------------------------------+
  • 2. Qualification, Education & Credentialing Requirements

Before an Oklahoma pharmacist may administer any vaccine, they must both complete training and obtain an immunization permit from the Board — the permit is a separate credential from the pharmacist license and is the step candidates most often omit.

A0. Board Immunization Permit (OAC 535:10-11-4)

The pharmacist must be licensed in Oklahoma and have completed the approved training described in 535:10-11-3.

The pharmacist applies for an immunization permit on a Board form and pays a $25 fee .

The permit must be displayed in the pharmacy where the pharmacist performs immunizations. Duplicates are available with a duplicate application and fee.

The Board maintains a register of pharmacists approved to administer immunizations (535:10-11-3(b)).

Intern exception: an Oklahoma-licensed intern who has successfully completed an approved immunization training program, while working under an Oklahoma-licensed pharmacist preceptor who holds immunization registration, is exempt from immunization registration — but must provide proof of the completed training program on Board request (535:10-11-4(d)).

Reinstatement trap: a pharmacist reinstating a lapsed license who previously held an immunization permit must submit verification of 2 hours of immunization-related ACPE-accredited CE with the reinstatement application to also reinstate the immunization permit; otherwise a new immunization application is required later.

Additional credentialing prerequisites under OAC 535:10-11-3 :

A. ACPE-Accredited Immunization Training Program

The practitioner must successfully complete a recognized training program accredited by the Accreditation Council for Pharmacy Education (ACPE) or an equivalent program approved by the Board (e.g., APhA Pharmacy-Based Immunization Delivery certificate program). The curriculum must cover:

Basic immunology and vaccine-preventable disease epidemiology.

CDC Advisory Committee on Immunization Practices (ACIP) vaccine schedules.

Intramuscular (IM), subcutaneous (SubQ), and intradermal injection techniques.

Safe storage, cold-chain maintenance, and vaccine handling (USP and CDC guidelines).

Emergency recognition and clinical management of acute anaphylactic shock.

OSHA Bloodborne Pathogens standard compliance and needle-stick safety.

B. Basic Cardiac Life Support (CPR / BLS) Certification

The immunizing pharmacist or intern must hold a current, active certification in Basic Cardiac Life Support (CPR / BLS) from the American Heart Association (AHA) or American Red Cross.

Annual CE requirement: OAC 535:10-11-3(c) requires a pharmacist with immunization registration to maintain ongoing competency through, at minimum, current CPR certification and 1 hour of immunization-related ACPE-accredited or Board-approved continuing education annually . This 1 hour sits inside — not on top of — the 15 hours of annual CE required for license renewal, but it is a specific hour that a general CE program will not satisfy.

C. Pharmacy Intern Scope

A registered pharmacy intern who has completed an approved ACPE immunization certificate program and maintains active CPR certification may administer vaccines only under the direct, personal supervision of an Oklahoma-licensed pharmacist who is also an authorized immunizer.

3. Patient Age Thresholds & Prescriptive Authority Scopes

A central focus of the Oklahoma MPJE is the precise statutory distinction regarding patient age: +------------------------------------------------------------------------------------------------+

  • | AGE-BASED IMMUNIZATION AUTHORITY IN OKLAHOMA |
  • +-----------------------+---------------------------------------+--------------------------------+
  • | Patient Age Group | Legal Dispensing Authority Required | Scope of Permitted Vaccines |
  • +-----------------------+---------------------------------------+--------------------------------+
  • | **Age 12 and Older** | **Physician Protocol / Standing Order**| All CDC/ACIP-recommended |
  • | (≥ 12 years of age) | (No individual Rx required) | vaccines (Flu, Tdap, HPV, |
  • | | | COVID-19, Pneumo, Zoster, etc.)|
  • +-----------------------+---------------------------------------+--------------------------------+
  • | **Under Age 12** | **Individual Patient-Specific Rx** | Vaccines specified in the |
  • | (< 12 years of age) | (Prescription from MD/DO/PA/APRN) | individual prescriber's order |
  • +-----------------------+---------------------------------------+--------------------------------+

Exam Distinction: Under Title 59 O.S. § 353.30(C), an appropriately trained and permitted Oklahoma pharmacist may administer an FDA-approved or FDA-authorized immunization at any age and without any prescriber involvement . What the pharmacist may not do without a prescriber's order is administer a therapeutic injection — the statute reserves those to "orders from a licensed prescriber." That immunization/therapeutic-injection line, not an age line, is the distinction Oklahoma actually draws. (While temporary federal PREP Act emergency declarations expanded pediatric authority during public health crises, standard Oklahoma statutory baseline sets the independent protocol line at age 12 and older ).

4. Pre-Administration Screening, VIS & Informed Consent

Prior to administering any immunization, the pharmacist must complete a standardized clinical safety protocol:

Pre-Vaccination Screening: Screen the patient for absolute contraindications and precautions using CDC screening questionnaires (e.g., severe allergies to eggs, gelatin, neomycin, or yeast; history of Guillain-Barré Syndrome within 6 weeks of previous vaccine; severe immunocompromise for live vaccines; pregnancy status; moderate-to-severe acute febrile illness).

Vaccine Information Statement (VIS): Under federal law (National Childhood Vaccine Injury Act of 1986, 42 U.S.C. § 300aa-26), the pharmacist must provide the most current official CDC VIS (or FDA EUA Fact Sheet) to the patient or adult legal guardian prior to administering each dose. The patient must be given adequate time to read the VIS and ask questions.

Informed Consent: The pharmacist must obtain a signed written or verifiable electronic informed consent form from the adult patient or the parent/legal guardian if the patient is a minor.

5. Emergency Anaphylaxis Response Protocol

Every Oklahoma pharmacy where immunizations are performed must maintain an emergency anaphylaxis kit immediately available at the administration station:

A. Emergency Supplies & Medication

Intramuscular Epinephrine: Epinephrine auto-injectors (e.g., EpiPen 0.3 mg for adults; EpiPen Jr 0.15 mg for pediatric patients) or Epinephrine 1 mg/mL (1:1000) aqueous solution vials with appropriate sterile syringes and needles.

Diphenhydramine: Oral tablets/liquid and/or injectable diphenhydramine (50 mg/mL).

Anaphylaxis Algorithm: Printed, laminated emergency treatment flowchart outlining dosing, IM injection into the anterolateral thigh (vastus lateralis), airway management, and calling 911.

B. Clinical Management Steps

Recognize acute anaphylaxis signs (bronchospasm, stridor, urticaria, facial angioedema, hypotension, circulatory collapse).

Administer IM Epinephrine immediately into the mid-anterolateral thigh.

Call 911 (Emergency Medical Services) immediately.

Place patient in supine position with legs elevated (unless airway compromise requires sitting up).

Repeat epinephrine every 5 to 15 minutes if symptoms persist or deteriorate before EMS arrives.

C. Mandatory Adverse Event Reporting (VAERS)

Any clinically significant adverse event, vaccine administration error, or condition listed in the VAERS Table of Reportable Events must be reported to the federal Vaccine Adverse Event Reporting System (VAERS) co-managed by the CDC and FDA.

6. Public Health Reporting (OSIIS) & Recordkeeping Mandates

Oklahoma law imposes strict post-administration reporting and record retention duties:

A. Oklahoma State Immunization Information System (OSIIS)

Under Oklahoma Department of Health rules, pharmacists administering vaccines must report all immunization data to the Oklahoma State Immunization Information System (OSIIS) registry. Reporting must occur within the statutory timeframe established by the state to maintain accurate statewide immunization tracking.

B. Primary Care Physician (PCP) Notification

If required under the collaborative physician standing order or requested by the patient, the pharmacy must provide written or electronic notification of the administered vaccine to the patient's primary care provider.

C. Record Retention

The pharmacy must maintain complete immunization records for at least two (2) years from the date of administration. The record must include:

Patient name, address, telephone number, DOB, and biological sex.

Date of administration.

Vaccine name, manufacturer, lot number, and expiration date.

Dose, route of administration, and anatomical site (e.g., right deltoid IM).

Edition date of the CDC VIS provided and date the VIS was delivered to the patient.

Name and license number of the administering pharmacist or supervised intern.

Signed patient/guardian informed consent form.

Loading diagram... Oklahoma Pharmacist Injection Authority: Immunization vs. Therapeutic Injection